{"id":7483,"date":"2023-06-09T12:53:06","date_gmt":"2023-06-09T09:53:06","guid":{"rendered":"https:\/\/www.neuroupclinic.com\/?post_type=avada_portfolio&#038;p=7483"},"modified":"2023-08-11T12:59:32","modified_gmt":"2023-08-11T12:59:32","slug":"ms-multiple-skleroz-tedavisi","status":"publish","type":"avada_portfolio","link":"https:\/\/tpsmedikal.com\/index.php\/portfolio-items\/ms-multiple-skleroz-tedavisi\/","title":{"rendered":"MS (Multiple Skleroz) Tedavisi"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;border-width: 0px 0px 0px 0px;border-color:#e2e2e2;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><style type=\"text\/css\">@media only screen and (max-width:1024px) {.fusion-title.fusion-title-1{margin-top:10px!important; margin-right:0px!important;margin-bottom:15px!important;margin-left:0px!important;}}@media only screen and (max-width:640px) {.fusion-title.fusion-title-1{margin-top:10px!important; margin-right:0px!important;margin-bottom:10px!important; margin-left:0px!important;}}<\/style><div class=\"fusion-title title fusion-title-1 fusion-title-text fusion-title-size-one\" style=\"margin-top:10px;margin-right:0px;margin-bottom:15px;margin-left:0px;\"><div class=\"title-sep-container title-sep-container-left fusion-no-large-visibility fusion-no-medium-visibility fusion-no-small-visibility\"><div class=\"title-sep sep-double sep-solid\" style=\"border-color:#e2e2e2;\"><\/div><\/div><span class=\"awb-title-spacer fusion-no-large-visibility fusion-no-medium-visibility fusion-no-small-visibility\"><\/span><h1 class=\"title-heading-left\" style=\"margin:0;\">MS (Multiple Skleroz) Tedavisi<\/h1><span class=\"awb-title-spacer\"><\/span><div class=\"title-sep-container title-sep-container-right\"><div class=\"title-sep sep-double sep-solid\" style=\"border-color:#e2e2e2;\"><\/div><\/div><\/div><div class=\"fusion-text fusion-text-1\"><h2>MS (Multiple Skleroz) Tedavisi Doktoru \u0130stanbul<\/h2>\n<p>Kad\u0131nlarda erkeklere nazaran iki kat daha fazla g\u00f6r\u00fclen, ba\u015flang\u0131\u00e7 ya\u015f\u0131 20-40 aras\u0131nda olan merkezi sinir sistemini etkileyen bir hastal\u0131kt\u0131r.\u00a0<strong>MS<\/strong>\u00a0hastal\u0131\u011f\u0131nda ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin yanl\u0131\u015f \u00e7al\u0131\u015fmas\u0131yla ile ili\u015fkili olarak beyin ve omurilikteki h\u00fccrelerin sinir k\u0131l\u0131flar\u0131na sald\u0131rmas\u0131 ile hasar g\u00f6rmesine neden olmaktad\u0131r. Sonras\u0131nda ise sinir h\u00fccreleri i\u015flevlerini gerekti\u011fi gibi yerine getirememektedir. (<a href=\"https:\/\/www.sureyyaataus.com\/hastaliklar\/ms-multiple-skleroz\/#ref1\">1<\/a>)<\/p>\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" class=\"lazyload aligncenter wp-image-1256 jetpack-lazy-image jetpack-lazy-image--handled\" src=\"https:\/\/i0.wp.com\/www.sureyyaataus.com\/wp-content\/uploads\/2022\/02\/multiple-skleroz-ms.webp?resize=840%2C281&amp;ssl=1\" data-orig-src=\"https:\/\/i0.wp.com\/www.sureyyaataus.com\/wp-content\/uploads\/2022\/02\/multiple-skleroz-ms.webp?resize=840%2C281&amp;ssl=1\" data-sizes=\"auto\" data-orig-sizes=\"(max-width: 840px) 100vw, 840px\" srcset=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27840%27%20height%3D%27281%27%20viewBox%3D%270%200%20840%20281%27%3E%3Crect%20width%3D%27840%27%20height%3D%27281%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-srcset=\"https:\/\/i0.wp.com\/www.sureyyaataus.com\/wp-content\/uploads\/2022\/02\/multiple-skleroz-ms.webp?w=840&amp;ssl=1 840w, https:\/\/i0.wp.com\/www.sureyyaataus.com\/wp-content\/uploads\/2022\/02\/multiple-skleroz-ms.webp?resize=300%2C100&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.sureyyaataus.com\/wp-content\/uploads\/2022\/02\/multiple-skleroz-ms.webp?resize=768%2C257&amp;ssl=1 768w\" alt=\"MS hastal\u0131\u011f\u0131\" width=\"840\" height=\"281\" data-recalc-dims=\"1\" data-lazy-loaded=\"1\" \/><\/figure>\n<h2 class=\"wp-block-heading\">MS Hastal\u0131\u011f\u0131 Nedir?<\/h2>\n<p><strong>MS (multiple skleroz) hastal\u0131\u011f\u0131<\/strong>\u00a0merkezi sinir sisteminde etkili olan ve kesin tedavisi olmayan ve ataklarla belirti veren bir hastal\u0131kt\u0131r. Kronik olan bu hastal\u0131k; merkezi sinir sistemindeki h\u00fccrelerin etraf\u0131n\u0131 saran miyelin k\u0131l\u0131f\u0131n\u0131n zarar g\u00f6rmesi halinde ortaya \u00e7\u0131kan bir hastal\u0131kt\u0131r. Miyelin k\u0131l\u0131f\u0131; n\u00f6ronlar aras\u0131nda elektriksel iletimi h\u0131zland\u0131rmaya yarayan ve h\u00fccreleri saran ya\u011fl\u0131 maddedir. (<a href=\"https:\/\/www.sureyyaataus.com\/hastaliklar\/ms-multiple-skleroz\/#ref1,2\">1,2<\/a>)<\/p>\n<h3><strong>Multiple Skleroz Hastal\u0131\u011f\u0131 Nedenleri Nedir?<\/strong><\/h3>\n<p><strong>MS hastal\u0131\u011f\u0131<\/strong>\u00a0otoimm\u00fcn yani ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin v\u00fccudun dokular\u0131na yanl\u0131\u015fl\u0131kla sald\u0131r\u0131 yapt\u0131\u011f\u0131 ve sonucunda da dokulara hasar verdi\u011fi hastal\u0131kt\u0131r. Nedeni tam olarak bilinmemektedir.<\/p>\n<h3><strong>Risk Fakt\u00f6rleri Nedir?<\/strong><\/h3>\n<p>Nedeni tam olarak bilinmeyen bu hastal\u0131k i\u00e7in belirli risk gruplar\u0131 vard\u0131r. Bu fakt\u00f6rler MS geli\u015ftirme riskini artt\u0131rabilir.<\/p>\n<ul>\n<li><strong>Ya\u015f<\/strong>; MS hastal\u0131\u011f\u0131 genellikle 20 ila 40 ya\u015f aras\u0131nda ortaya \u00e7\u0131kmaktad\u0131r. Ancak gen\u00e7 ve ya\u015fl\u0131 grubunda da ortaya \u00e7\u0131kabilir.<\/li>\n<li>Kad\u0131nlar erkeklere nazaran 2-3 kat daha fazla g\u00f6r\u00fclebilir.<\/li>\n<li><strong>Genetik<\/strong>; aile \u00f6yk\u00fcs\u00fcnde bu hastal\u0131k bulunuyorsa hastal\u0131\u011fa yakalanma riski daha y\u00fcksektir.<\/li>\n<li><strong>Baz\u0131 enfeksiyonlar<\/strong><\/li>\n<li><strong>Co\u011frafya-iklim<\/strong>; ki\u015finin do\u011fdu\u011fu co\u011frafya iklim etkili olabilmektedir. \u00d6rne\u011fin \u0131l\u0131man iklime sahip \u00fclkelerde g\u00f6r\u00fclme olas\u0131l\u0131\u011f\u0131 daha fazlad\u0131r.<\/li>\n<li><strong>D vitamini d\u00fc\u015f\u00fckl\u00fc\u011f\u00fc<\/strong>; g\u00fcne\u015f \u0131\u015f\u0131\u011f\u0131ndan yeterince yararlanamayan ve D vitamini eksikli\u011fi ya\u015fayan ki\u015filerde yatk\u0131nl\u0131k g\u00f6r\u00fclebilir.<\/li>\n<li><strong>Baz\u0131 otoimm\u00fcn hastal\u0131klar<\/strong>; Ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin do\u011fru \u00e7al\u0131\u015fmamas\u0131 ile ili\u015fkili olan hastal\u0131klar etkili olabilir. \u00d6rne\u011fin; sedef, inflamatuar ba\u011f\u0131rsak hastal\u0131\u011f\u0131\u2026 (<a href=\"https:\/\/www.sureyyaataus.com\/hastaliklar\/ms-multiple-skleroz\/#ref3\">3<\/a>)<\/li>\n<\/ul>\n<h3 class=\"wp-block-heading\"><strong>MS Belirtileri Nedir?<\/strong><\/h3>\n<ul>\n<li>Mesane problemleri,<\/li>\n<li>Yorgunluk,<\/li>\n<li>G\u00f6rme problemleri,<\/li>\n<li>Bellek-konsantrasyon bozukluklar\u0131,<\/li>\n<li>\u0130\u015fitme kayb\u0131,<\/li>\n<li>Epileptik n\u00f6bet ba\u015fa\u011fr\u0131s\u0131,<\/li>\n<li>Hareket bozukluklar\u0131,<\/li>\n<li>G\u00fc\u00e7s\u00fczl\u00fck (<a href=\"https:\/\/www.sureyyaataus.com\/hastaliklar\/ms-multiple-skleroz\/#ref4\">4<\/a>).<\/li>\n<\/ul>\n<h3><strong><img decoding=\"async\" class=\"lazyload aligncenter wp-image-1257 jetpack-lazy-image jetpack-lazy-image--handled\" src=\"https:\/\/i0.wp.com\/www.sureyyaataus.com\/wp-content\/uploads\/2022\/02\/ms-hastaligi.webp?resize=800%2C401&amp;ssl=1\" data-orig-src=\"https:\/\/i0.wp.com\/www.sureyyaataus.com\/wp-content\/uploads\/2022\/02\/ms-hastaligi.webp?resize=800%2C401&amp;ssl=1\" data-sizes=\"auto\" data-orig-sizes=\"(max-width: 800px) 100vw, 800px\" srcset=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27800%27%20height%3D%27401%27%20viewBox%3D%270%200%20800%20401%27%3E%3Crect%20width%3D%27800%27%20height%3D%27401%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-srcset=\"https:\/\/i0.wp.com\/www.sureyyaataus.com\/wp-content\/uploads\/2022\/02\/ms-hastaligi.webp?w=369&amp;ssl=1 369w, https:\/\/i0.wp.com\/www.sureyyaataus.com\/wp-content\/uploads\/2022\/02\/ms-hastaligi.webp?resize=300%2C150&amp;ssl=1 300w\" alt=\"MS (Multiple Skleroz) Tedavisi Doktoru \u0130stanbul\" width=\"800\" height=\"401\" data-recalc-dims=\"1\" data-lazy-loaded=\"1\" \/><\/strong><\/h3>\n<h3><strong>MS Klinik Seyir Tipleri Nelerdir?<\/strong><\/h3>\n<p>Klinik seyri be\u015f ba\u015fl\u0131k alt\u0131nda de\u011ferlendirilmi\u015ftir;<\/p>\n<ul>\n<li><strong>Relapsing-remitting (RRMS);<\/strong>\u00a0ataklar\u0131n olmas\u0131yla birlikte hastan\u0131n k\u00f6t\u00fcle\u015fti\u011fi, ara d\u00f6nemlerde hastan\u0131n d\u00fczelme g\u00f6sterdi\u011fi d\u00f6nemdir.<\/li>\n<li><strong>Sekonder progresif (SPMS);<\/strong>\u00a05-6 y\u0131ll\u0131k bir s\u00fcre\u00e7ten sonra ikincil ilerleyici d\u00f6nemdir. Atak say\u0131s\u0131n\u0131n azald\u0131\u011f\u0131 d\u00f6nemdir. ikincil ilerleyici MS olarak da bilinen bu t\u00fcrde hastal\u0131\u011f\u0131n n\u00fcksetti\u011fi durumdan geri toparlanmas\u0131 m\u00fcmk\u00fcn olmamaktad\u0131r.<\/li>\n<li><strong>Progresif-Relapsing;<\/strong>\u00a0ilerlemelerin devam etti\u011fi d\u00f6nemdir.<\/li>\n<li><strong>Primer Progresif (PPMS);\u00a0<\/strong>hastal\u0131\u011f\u0131n ba\u015flang\u0131c\u0131ndan itibaren genellikle iyile\u015fme olmad\u0131\u011f\u0131, hastal\u0131\u011f\u0131n ilerlemesinin h\u0131zl\u0131 ya da yava\u015f oldu\u011fu d\u00f6nemlerdir. Birincil ilerleyici MS hastal\u0131\u011f\u0131n\u0131n \u00e7e\u015fitleri aras\u0131nda en tehlikeli olan\u0131 olarak belirtilmi\u015ftir.<\/li>\n<li><strong>\u0130yi huylu (Benign);\u00a0<\/strong>akut ataklar\u0131ndan sonra devam eden d\u00f6nemlerde tama yak\u0131n d\u00fczelme g\u00f6r\u00fclebilir. Ataklar aras\u0131nda hastal\u0131kta ilerleme g\u00f6zlenmemektedir. (<a href=\"https:\/\/www.sureyyaataus.com\/hastaliklar\/ms-multiple-skleroz\/#ref5\">5<\/a>)<\/li>\n<\/ul>\n<h3><strong>MS Tan\u0131s\u0131 Nas\u0131l Konulmaktad\u0131r?<\/strong><\/h3>\n<p>\u0130stanbul<strong>\u00a0MS hastal\u0131\u011f\u0131<\/strong>\u00a0tan\u0131s\u0131 i\u00e7in \u00f6ncelikle yukar\u0131da yer alan belirtileri de g\u00f6z \u00f6n\u00fcne alarak doktora ba\u015fvuru yapman\u0131z gerekmektedir. MS hastal\u0131\u011f\u0131na benzer di\u011fer hastal\u0131klar\u0131n da semptomlar\u0131 olabilece\u011finden yap\u0131lacak ay\u0131r\u0131c\u0131 testlerin ard\u0131ndan te\u015fhis konulabilir.<\/p>\n<p>Hastal\u0131\u011f\u0131n tan\u0131s\u0131nda \u00f6ncelikle ba\u015fvurulan y\u00f6ntem belirtilerin de\u011ferlendirilmesi ve muayene ile ba\u015flamaktad\u0131r. Sonras\u0131nda ise beyin veya omurilik MR, beyin omurilik s\u0131v\u0131s\u0131n\u0131n incelenmesi yine hastal\u0131\u011f\u0131n te\u015fhisi i\u00e7in uygulanmaktad\u0131r. Ayr\u0131ca hastalar\u0131n tek atak ge\u00e7irmesinden ziyade en az 2 ata\u011f\u0131n\u0131n olmas\u0131 veya tekrarlayan beyin ve omurilik MR\u2019lar\u0131nda plak say\u0131s\u0131n\u0131n art\u0131\u015f\u0131n\u0131n olup olmad\u0131\u011f\u0131na bak\u0131lmaktad\u0131r. (MS pla\u011f\u0131; hastalar\u0131n beyin veya omuriliklerinde hastal\u0131\u011fa \u00f6zg\u00fc doku de\u011fi\u015fiklikleri g\u00f6r\u00fclmektedir. Zarar g\u00f6ren miyelin k\u0131l\u0131flar\u0131 sonras\u0131 hasar g\u00f6ren bu b\u00f6lgeler plak olarak adland\u0131r\u0131lmaktad\u0131r.) (<a href=\"https:\/\/www.sureyyaataus.com\/hastaliklar\/ms-multiple-skleroz\/#ref5\">5<\/a>,<a href=\"https:\/\/www.sureyyaataus.com\/hastaliklar\/ms-multiple-skleroz\/#ref6\">6<\/a>)<\/p>\n<h3 class=\"wp-block-heading\">MS Tedavisi Nas\u0131l Olur?<\/h3>\n<p>\u0130stanbul MS tedavisinde kesin \u00e7\u00f6z\u00fcm olmamakla birlikte ila\u00e7larla ve ya\u015fam tarz\u0131 de\u011fi\u015fikleriyle hastal\u0131k kontrol alt\u0131nda tutulabilir<strong>.<\/strong><\/p>\n<ul>\n<li><strong>Atak tedavisi:<\/strong>\u00a0ataklar aras\u0131nda uygulanan tedavi y\u00f6ntemidir. Ata\u011f\u0131n k\u0131sa s\u00fcrmesini ve tedavisi i\u00e7in y\u00fcksek doz kortizonlar kullan\u0131lmaktad\u0131r.<\/li>\n<li><strong>Koruyucu tedavi:<\/strong>\u00a0Ataklar\u0131n tekrarlamas\u0131n\u0131 azaltarak, \u00e7ekilen MR\u2019larda yeni plaklar\u0131n olu\u015fmas\u0131n\u0131 engellemek ama\u00e7lanmaktad\u0131r. Yap\u0131lan bu tedavilerle ataklar \u00f6nlenebilir.<\/li>\n<li><strong>Belirtileri giderici tedaviler:<\/strong>\u00a0Ayr\u0131ca MS hastal\u0131\u011f\u0131 ve semptomlar\u0131 ile ilgili bilgi verilerek yapabilecekleri gibi bilgilendirme yap\u0131lmas\u0131 gereken s\u00fcre\u00e7tir. A\u011fr\u0131 kesiciler, kas gev\u015fetici, epilepsi ila\u00e7lar\u0131, germe egzersizleri gibi y\u00f6ntemlerle tedavi edilebilir.<\/li>\n<li><strong>Fizyoterapi:<\/strong>\u00a0MS hastalar\u0131nda \u00f6nemli bir yer tutan fizik tedavi ile hastalar\u0131n g\u00fc\u00e7 kayb\u0131n\u0131, dengesizlik ve kas sertliklerini \u00f6nlemek amac\u0131yla yap\u0131lmaktad\u0131r. (<a href=\"https:\/\/www.sureyyaataus.com\/hastaliklar\/ms-multiple-skleroz\/#ref7\">7<\/a>)<\/li>\n<\/ul>\n<p>Ya\u015fam tarz\u0131n\u0131za yapabilece\u011finiz k\u00fc\u00e7\u00fck dokunu\u015flarla tedavi s\u00fcrecinde destek olacakt\u0131r.<\/p>\n<ul>\n<li>Sa\u011fl\u0131kl\u0131 bir uyku ile bol bol dinlenin. \u00d6zellikle teknolojinin her an yan\u0131m\u0131zda oldu\u011funu d\u00fc\u015f\u00fcn\u00fcrsek \u0131\u015f\u0131klar\u0131n uykumuzu olumsuz y\u00f6nde etkiledi\u011finin fark\u0131nday\u0131z. MS hastalar\u0131 i\u00e7in \u00f6zellikle uyuduklar\u0131 ortam\u0131n karanl\u0131k, serin olmas\u0131 \u00f6nemlidir.<\/li>\n<li>Egzersizlerle kaslar\u0131n\u0131z\u0131 ve kemiklerinizi g\u00fc\u00e7lendirebilirsiniz. Kaliteli uykunuza fayda sa\u011flayacak olan egzersizleri ihmal etmeyin.<\/li>\n<li>Stresi m\u00fcmk\u00fcn oldu\u011funca uzakla\u015ft\u0131r\u0131n. Kimi zaman kitap okumakla, kimi zaman y\u00fcr\u00fcy\u00fc\u015fle stres kontrol\u00fc yapmaya \u00e7al\u0131\u015f\u0131n.<\/li>\n<li>Belirtileri aras\u0131nda yer alan D vitamini seviyenizi kontrol alt\u0131nda tutarak bu y\u00f6nde ila\u00e7 kullanabilirsiniz.<\/li>\n<\/ul>\n<h2>MS (Multipl Skleroz) Hastal\u0131\u011f\u0131 Kendini Nas\u0131l Belli Eder?<\/h2>\n<p><strong>Multiple skleroz (MS)<\/strong>\u00a0merkezi sinir sistemini etkileyen bir kronik otoimm\u00fcn hastal\u0131kt\u0131r ve belirtileri aras\u0131nda g\u00f6rme bozukluklar\u0131, iskelet kas\u0131 s\u0131k\u0131nt\u0131lar\u0131, denge ve d\u00fc\u015fme bozukluklar\u0131, idrar ka\u00e7\u0131rma ve duyu bozukluklar\u0131 gibi belirtiler say\u0131labilir. Bu belirtiler, MS hastal\u0131\u011f\u0131n\u0131n belirtileri aras\u0131nda yer al\u0131r ancak her ki\u015fi i\u00e7in ge\u00e7erli olmayabilir ve bireyler aras\u0131nda farkl\u0131l\u0131klar g\u00f6sterebilir. Bu nedenle, MS hastal\u0131\u011f\u0131 olan ki\u015filerin doktorlar\u0131yla birlikte en uygun tedavi y\u00f6ntemlerini belirlemeleri \u00f6nerilir.<\/p>\n<h2>MS hastal\u0131\u011f\u0131n\u0131 yenmek m\u00fcmk\u00fcn m\u00fc?<\/h2>\n<p><strong>Multiple skleroz (MS)<\/strong>\u00a0merkezi sinir sistemini etkileyen bir kronik otoimm\u00fcn hastal\u0131kt\u0131r ve \u015fu anda tamamen iyile\u015ftirilebilir bir hastal\u0131k de\u011fildir. Ancak, MS hastal\u0131\u011f\u0131n\u0131n belirtilerini azaltmak ve hastal\u0131\u011f\u0131n ilerlemesini yava\u015flatmak m\u00fcmk\u00fcnd\u00fcr ve bu ama\u00e7la kullan\u0131lan y\u00f6ntemler aras\u0131nda ila\u00e7lar, fizik tedavi, diyet ve psikolojik destek say\u0131labilir. Bu y\u00f6ntemler, her ki\u015fi i\u00e7in ge\u00e7erli olmayabilir ve bireyler aras\u0131nda farkl\u0131l\u0131klar g\u00f6sterebilir. \u0130stanbul MS hastal\u0131\u011f\u0131 tedavisi i\u00e7in ki\u015filere doktorlar\u0131yla birlikte en uygun tedavi y\u00f6ntemlerini belirlemeleri \u00f6nerilir.<\/p>\n<h2>MS Hastal\u0131\u011f\u0131 en \u00e7ok kimlerde g\u00f6r\u00fcl\u00fcr?<\/h2>\n<p><strong>Multiple skleroz (MS)<\/strong>\u00a0merkezi sinir sistemini etkileyen bir kronik otoimm\u00fcn hastal\u0131kt\u0131r ve her ya\u015fta g\u00f6r\u00fclebilir ancak 20-40 ya\u015f aras\u0131nda g\u00f6r\u00fclme olas\u0131l\u0131\u011f\u0131 daha y\u00fcksektir. Erkeklerde ve kad\u0131nlarda e\u015fit olarak g\u00f6r\u00fcl\u00fcr ancak kad\u0131nlarda daha s\u0131k g\u00f6r\u00fcl\u00fcr. MS hastal\u0131\u011f\u0131, her \u00fclkede g\u00f6r\u00fcl\u00fcr ancak y\u00fcksek prevalans g\u00f6steren \u00fclkeler aras\u0131nda ABD, Avustralya, Kanada, \u0130sve\u00e7, Norve\u00e7, Danimarka, \u0130ngiltere, \u0130rlanda ve Almanya say\u0131labilir. Bu \u00fclkelerde, MS hastal\u0131\u011f\u0131n\u0131n s\u0131kl\u0131\u011f\u0131 y\u00fcksektir ancak bu nedenle MS hastal\u0131\u011f\u0131n\u0131n daha yayg\u0131n oldu\u011fu anlam\u0131na gelmez.<\/p>\n<p><strong>Referanslar:<\/strong><\/p>\n<p><span id=\"ref1\">1.Seki \u00d6z, H. (2013). Multiple Skleroz Lu Hastalar\u0131n Stresle Ba\u015f Etme Tarzlar\u0131n\u0131n ve Psikiyatrik Belirtilerinin De\u011ferlendirilmesi.<\/span><\/p>\n<p><span id=\"ref2\">2.Haberler, B., &amp; Hizmetleri, B. T. Multiple Skleroz.<\/span><\/p>\n<p><span id=\"ref3\">3.NED\u0130R, M. MS, Uykular\u0131n\u0131z\u0131 \u00c7almas\u0131n.<\/span><\/p>\n<p><span id=\"ref4\">4.Mutluay, F. K. (2006).\u00a0<a href=\"https:\/\/jag.journalagent.com\/tjn\/pdfs\/TJN_12_2_134_143.pdf\" target=\"_blank\" rel=\"noopener\">Multipl skleroz rehabilitasyonu<\/a>.\u00a0<i>T\u00fcrk N\u00f6roloji Dergisi<\/i>,\u00a0<i>12<\/i>(2), 134-143.<\/span><\/p>\n<p><span id=\"ref5\">5.\u00d6zb\u00fclb\u00fcl, D., &amp; Demirhan, \u0130. (2012). MULT\u0130PLE SKLEROZ BEL\u0130RT\u0130LER\u0130, TANI VE TEDAV\u0130S\u0130.<\/span><\/p>\n<p><span id=\"ref6\">6.Karata\u015f, M. (2008). Multiple Sklerozda Ay\u0131r\u0131c\u0131 Tan\u0131. Journal of Neurological Sciences, 25(2).<\/span><\/p>\n<p><span id=\"ref7\">7.ULUCAN-KARNAK, F. (2020). MULTIPL SKLEROZ HASTALI\u011eINA KAR\u015eI TEDAV\u0130 YAKLA\u015eIMLARI. ER\u00dc Sa\u011fl\u0131k Bilimleri Fak\u00fcltesi Dergisi, 7(2), 49-54.<\/span><\/p>\n<\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-0{width:100% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-column-0 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 1.92%;padding-bottom : 0px !important;padding-left : 0px !important;margin-left : 1.92%;}@media only screen and (max-width:1024px) {.fusion-body .fusion-builder-column-0{width:100% !important;order : 0;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-0{width:100% !important;order : 0;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-flex-container.fusion-builder-row-1{ padding-top : 0px;margin-top : 0px;padding-right : 0px;padding-bottom : 0px;margin-bottom : 0px;padding-left : 0px;}<\/style><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":7644,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","format":"standard","meta":{"_joinchat":[],"footnotes":""},"portfolio_category":[19],"portfolio_skills":[],"portfolio_tags":[13],"class_list":["post-7483","avada_portfolio","type-avada_portfolio","status-publish","format-standard","has-post-thumbnail","hentry","portfolio_category-noroloji","portfolio_tags-ms-multiple-skleroz-tedavisi"],"_links":{"self":[{"href":"https:\/\/tpsmedikal.com\/index.php\/wp-json\/wp\/v2\/avada_portfolio\/7483","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tpsmedikal.com\/index.php\/wp-json\/wp\/v2\/avada_portfolio"}],"about":[{"href":"https:\/\/tpsmedikal.com\/index.php\/wp-json\/wp\/v2\/types\/avada_portfolio"}],"author":[{"embeddable":true,"href":"https:\/\/tpsmedikal.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/tpsmedikal.com\/index.php\/wp-json\/wp\/v2\/comments?post=7483"}],"version-history":[{"count":1,"href":"https:\/\/tpsmedikal.com\/index.php\/wp-json\/wp\/v2\/avada_portfolio\/7483\/revisions"}],"predecessor-version":[{"id":7571,"href":"https:\/\/tpsmedikal.com\/index.php\/wp-json\/wp\/v2\/avada_portfolio\/7483\/revisions\/7571"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tpsmedikal.com\/index.php\/wp-json\/wp\/v2\/media\/7644"}],"wp:attachment":[{"href":"https:\/\/tpsmedikal.com\/index.php\/wp-json\/wp\/v2\/media?parent=7483"}],"wp:term":[{"taxonomy":"portfolio_category","embeddable":true,"href":"https:\/\/tpsmedikal.com\/index.php\/wp-json\/wp\/v2\/portfolio_category?post=7483"},{"taxonomy":"portfolio_skills","embeddable":true,"href":"https:\/\/tpsmedikal.com\/index.php\/wp-json\/wp\/v2\/portfolio_skills?post=7483"},{"taxonomy":"portfolio_tags","embeddable":true,"href":"https:\/\/tpsmedikal.com\/index.php\/wp-json\/wp\/v2\/portfolio_tags?post=7483"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}